-- ユニキュア（QURE）は木曜日、ハンチントン病治療薬AMT-130について、第3四半期に英国での販売承認申請を行う予定であると発表した。 同社によると、申請の決定は、英国医薬品・医療製品規制庁（MHRA）との事前協議を経て行われた。 また、同社は第2四半期に米国食品医薬品局（FDA）とのタイプB協議の許可を得ており、第3四半期には第III相臨床試験の設計に関する主要な要素について協議し、解析計画に関するフィードバックを受ける予定であると述べた。 同社は、AMT-130の国際市場における承認取得に向けて、他の規制経路も積極的に模索しており、下半期にさらなる最新情報を提供する予定であると述べた。
Price: $19.02, Change: $+2.29, Percent Change: +13.66%
(Updates with stock price move in headline and first paragraph, full-year revenue guidance and analyst downgrade in the sixth and seventh paragraphs.)Check Point Software Technologies (CHKP) shares were down more than 19% in Thursday afternoon trading after the company cut its full-year revenue outlook and Piper Sandler downgraded the stock.The company reported Q1 non-GAAP earnings Thursday of $2.50 per diluted share, up from $2.21 a year earlier.Analysts polled by FactSet expected $2.40.Revenue for the quarter ended March 31 was $668.4 million, up from $637.8 million a year earlier.Analysts surveyed by FactSet expected $672.7 million.The company lowered its 2026 revenue forecast to between $2.77 billion and $2.85 billion from $2.83 billion to $2.95 billion. Analysts expected $2.88 billion.Piper Sandler downgraded the stock to neutral from overweight.Price: $112.94, Change: $-27.02, Percent Change: -19.31%
Tech stocks rose late Thursday afternoon with the State Street Technology Select Sector SPDR ETF (XLK) gaining 0.2% and the State Street SPDR S&P Semiconductor ETF (XSD) advancing 4.1%.The Philadelphia Semiconductor index climbed 2%.In corporate news, Qualcomm's (QCOM) shares jumped 15% a day after the company posted better-than-expected fiscal Q2 adjusted earnings and revenue.
Adamas Trust (ADAM) shares were up 16.4% in Thursday trading after the real estate investment trust posted better-than-expected Q1 earnings.The company reported earnings of $0.40 per diluted share, compared with $0.33 a year ago.Analysts polled by FactSet expected $0.12.Revenue for the quarter ended March 31, expressed as the sum of total net interest income and total other income, was $129.4 million, compared with $65.1 million a year earlier.A comparable FactSet estimate was not available.Price: $9.00, Change: $+1.25, Percent Change: +16.06%